Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$42.97
1.754.25%
Last update: Oct 19, 4:00 PM
$42.97
1.754.25%
Alkermes PLC (ALKS) Stock Price, Quote, News & History
ALKSNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Alkermes (NASDAQ:ALKS) through any online brokerage.
Other companies in Alkermes’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Alkermes has a consensus price target of $52.63.
The stock price for Alkermes (NASDAQ: ALKS) is $42.97 last updated October 19, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Alkermes.
Alkermes does not have any upcoming earnings scheduled.
There is no upcoming split for Alkermes.
Alkermes is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
